Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort study
View ORCID ProfilePeiyuan Huang, Haibo Tang, Zeying Feng, Evie Stergiakouli, View ORCID ProfileTom R Gaunt, View ORCID ProfileJie Zheng, View ORCID ProfileYao Lu
doi: https://doi.org/10.1101/2024.09.09.24313366
Peiyuan Huang
1Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
2Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China
3Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the People’s Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China
4Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
Haibo Tang
5Clinical Research Center, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, Hunan, 410013, China
6Department of Metabolic and Bariatric Surgery, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, Hunan, 410013, China
Zeying Feng
7Clinical Trial Institution Office, Liuzhou Hospital of Guangzhou Women and Children’s Medical Center, 50 Boyuan Avenue, Liuzhou, Guangxi, 545006, China
Evie Stergiakouli
1Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
4Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
Tom R Gaunt
1Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
4Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
8National Institute for Health and Care Research Bristol Biomedical Research Centre, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
Jie Zheng
1Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
2Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China
3Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the People’s Republic of China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China
Yao Lu
5Clinical Research Center, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, Hunan, 410013, China
9School of Life Course Sciences, King’s College London, Addison House, Guy’s Campus, London, SE1 1UL, United Kingdom
Article usage
Posted September 24, 2024.
Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort study
Peiyuan Huang, Haibo Tang, Zeying Feng, Evie Stergiakouli, Tom R Gaunt, Jie Zheng, Yao Lu
medRxiv 2024.09.09.24313366; doi: https://doi.org/10.1101/2024.09.09.24313366
Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort study
Peiyuan Huang, Haibo Tang, Zeying Feng, Evie Stergiakouli, Tom R Gaunt, Jie Zheng, Yao Lu
medRxiv 2024.09.09.24313366; doi: https://doi.org/10.1101/2024.09.09.24313366
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2875)
- Dermatology (244)
- Emergency Medicine (432)
- Epidemiology (12599)
- Forensic Medicine (10)
- Gastroenterology (810)
- Genetic and Genomic Medicine (4473)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4230)
- Nursing (226)
- Nutrition (619)
- Oncology (2217)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)